3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13
Endometrial Neoplasms
2
Carcinoma, Ductal, Breast
2
Peritoneal Neoplasms
1
Fallopian Tube Neoplasms
1
Cystadenocarcinoma, Serous
1
Carcinoma, Lobular
1
Breast Neoplasms, Male
1
Breast Neoplasm Female
1
Breast Carcinoma In Situ
1
Breast Cancer Invasive Nos
1
Advanced, Persistent, or Recurrent Endometrial Cancer
1
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Triptorelin Pamoate
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Cancer Invasive Nos
×
Letrozole
×
Clear all
NCT02005887
2019-05-29
TREND
ETOP IBCSG Partners Foundation
Phase 2
Completed
51 enrolled
10 charts